<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Health policy</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Health policy.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/topics/health-policy.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Mathematical Model and Analysis of Leptospirosis Transmission Dynamics in Human and Dog Populations.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-62054-ijdm-0303-24-4e33d7b6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-62054-ijdm-0303-24-4e33d7b6/</guid>
    <pubDate>Tue, 08 Sep 2026 00:00:00 GMT</pubDate>
    <description>The findings offer insights for public health policy in communities affected by leptospirosis, particularly regarding the need for integrated interventions targeting environmental conditions and infection treatment across species.</description>
    <category>Leptospirosis</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>One Health</category>
    <category>Health policy</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Factors that impact on healthcare workers&apos; adherence with infection prevention and control (IPC) guidelines for COVID-19: a qualitative evidence synthesis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016384-84f72db7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016384-84f72db7/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The review offers implications for practice, including communication strategies, training, and supply provision, intended to support policymakers and decision-makers managing IPC during ongoing and future pandemic responses.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Influenza</category>
    <category>Health policy</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Artemisinin partial resistance at a crossroads: evidence for continental variation in Plasmodium falciparum clearance phenotypes</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00132-5-db535b09/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00132-5-db535b09/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Applying southeast Asia-derived clearance thresholds in Africa may obscure early signals of artemisinin partial resistance and delay policy responses, supporting the need for region-specific surveillance criteria.</description>
    <category>Malaria</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Streptococcus suis meningitis complicated with communicating hydrocephalus: complete clinical and radiological resolution with non-neurosurgical management—A case report</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1888345-083371ad/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1888345-083371ad/</guid>
    <pubDate>Fri, 28 Aug 2026 00:00:00 GMT</pubDate>
    <description>The case suggests that contrast-enhanced MRI for accurate hydrocephalus subtyping and rapid pathogen identification via metagenomic sequencing may inform decisions about non-neurosurgical management in selected S. suis meningitis cases with communicating hydrocephalus.</description>
    <category>Streptococcus suis</category>
    <category>Treatment</category>
    <category>One Health</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Multistakeholder Consultations on Programmatic Progress, Challenges, and Policy Priorities for Lymphatic Filariasis Elimination in India</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4269-ajtmh-26-0054-7a6f8f75/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4269-ajtmh-26-0054-7a6f8f75/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesized recommendations supply practical frameworks for adjusting national control campaigns, optimizing funding deployment, and mitigating structural impediments that delay disease clearance objectives.</description>
    <category>Filariasis</category>
    <category>Health policy</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Understanding moral trade-offs in pandemic response: A discrete choice experiment on avian influenza policies.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1007-s10198-026-01985-6-b3161585/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1007-s10198-026-01985-6-b3161585/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest that public acceptance of preparedness policies may depend on perceived moral legitimacy as well as expected effectiveness and financial cost. The abstract reports that incorporating these preference differences into economic evaluation could inform consideration of societal acceptability.</description>
    <category>Influenza</category>
    <category>Outbreak investigation</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Impact of COVID-19 on neglected tropical diseases in Zambia: a qualitative study of stakeholder perspectives</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01491-0-094906d7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01491-0-094906d7/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The results emphasize the importance of predictable domestic funding, robust monitoring systems, and sustainable local partnerships to maintain endemic disease control during systemic crises.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>One Health</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Health policy</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Hemoadsorption Therapy for Expanded Dengue Syndrome Patients : A Case Series Study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3329-jcmcta-v37i1-91645-b980d6a0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3329-jcmcta-v37i1-91645-b980d6a0/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>Expanded dengue syndrome represents a rare but severe manifestation of dengue infection with multi-organ involvement and high fatality risk. The case series suggests hemoadsorption may offer a treatment option when standard intensive care fails, though the evidence base is limited to three cases.</description>
    <category>Dengue</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Interventions for preventing dengue: a mapping review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016299-pub2-93bce51c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016299-pub2-93bce51c/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors highlight that the main challenge is not a lack of primary studies but the absence of strategic synthesis aligned with decision-making, and call for greater emphasis on epidemiological and implementation outcomes beyond entomological endpoints to support scalable dengue control, particularly in endemic and resource-constrained settings.</description>
    <category>Dengue</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Management of neonates born to mothers with reactive serologic tests for syphilis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1097-qco-0000000000001234-117d9b89/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1097-qco-0000000000001234-117d9b89/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The review is framed around the U.S. resurgence of maternal and congenital syphilis, noting associated neonatal morbidity and mortality and calling for more practical, safe management approaches.</description>
    <category>Syphilis</category>
    <category>Congenital syphilis</category>
    <category>Syphilis in pregnancy</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Global, Regional and National Trends in Latent Tuberculosis Infection Prevalence From 1990 to 2023, With Projections to 2050</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-24976-discov-med-202638211-205-da1dffa9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-24976-discov-med-202638211-205-da1dffa9/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors argue that sustained declines in standardized LTBI rates co-exist with a growing absolute caseload, implying that TB elimination efforts require prevention-oriented policies targeting progression to active disease, especially in ageing and other high-risk populations.</description>
    <category>Tuberculosis</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Pradefovir mesylate and tenofovir amibufenamide for chronic hepatitis B: a systematic review and pragmatic treatment algorithm</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fphar-2026-1862886-7d080baa/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fphar-2026-1862886-7d080baa/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The manuscript consolidates comparative safety and efficacy data to inform clinical guidelines regarding newly approved nucleotide prodrugs for chronic hepatitis B management.</description>
    <category>Hepatitis B</category>
    <category>Chronic hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Mapping the Surveillance Data Infrastructure in the U.S. for SARS-CoV-2, Influenza, and Respiratory Syncytial Virus</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1007-s40471-026-00405-w-511150c9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1007-s40471-026-00405-w-511150c9/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>Clarifying the scope and availability of these monitoring frameworks may streamline epidemiological investigations and support more effective emergency management strategies.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Negotiating security and resilience: planning conundrums for avian influenza control in Great Britain’s poultry systems</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1088-2976-601x-ae8dd4-7e93f829/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1088-2976-601x-ae8dd4-7e93f829/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The research highlights critical gaps in agricultural risk management that could facilitate pathogen persistence and impact broader food security frameworks.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>One Health</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Progress toward poliomyelitis eradication — January 2023–December 2024</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s13690-026-02047-2-9b6ef2f5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s13690-026-02047-2-9b6ef2f5/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings highlight the continued risk posed by persistent WPV1 transmission in endemic areas and the geographic spread of cVDPVs, informing the need for improved campaign quality, sustained surveillance, expanded nOPV2 use where cVDPV2 transmission persists, and strategic resource allocation under declining global health funding.</description>
    <category>Poliomyelitis</category>
    <category>Acute flaccid paralysis</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Building Resilient Agricultural Value Chains in the Global South Post COVID-19</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-covid6080148-2608d6ae/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-covid6080148-2608d6ae/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>The work addresses food security, a key public health concern, by linking pandemic-related value chain disruption in the Global South to policy options for resilience.</description>
    <category>COVID-19</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Pfizer Versus Moderna COVID-19 Vaccine Effectiveness Against Mortality: Evidence from Linked Mortality and Vaccination Records in Indiana</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080717-24db60bc/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080717-24db60bc/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors frame the findings as relevant to vaccination policy, arguing that controlling for healthy-vaccinee bias is important when comparing vaccine effectiveness and that, during a period of high vaccine availability and COVID-19 mortality, Moderna was associated with lower COVID-19 mortality than Pfizer. A higher Moderna dose is suggested as a possible explanation.</description>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Social Judgment of the Polish Government Policy to Support Enterprises during Pandemic COVID-19 – An Analysis of Financial Shields</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-14746-pp-2026-31-2-9-244d3704/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-14746-pp-2026-31-2-9-244d3704/</guid>
    <pubDate>Wed, 19 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings document policy responses aimed at mitigating economic consequences of pandemic-related disruptions, including effects on employment and business continuity.</description>
    <category>COVID-19</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Trends and patterns of varicella zoster virus infection in Kilifi: A population-based serosurvey</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pgph-0006013-e7f7fafa/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pgph-0006013-e7f7fafa/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>Widespread adult susceptibility points to potential vulnerabilities for severe clinical outcomes in mature cohorts and expectant mothers, underscoring the potential value of introducing pediatric vaccination initiatives.</description>
    <category>Varicella</category>
    <category>Zoster</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Factors associated with severe COVID-19 outcomes among adults with at least a primary vaccination schedule: A retrospective cohort study from Alberta, Canada</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354822-21d017fb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354822-21d017fb/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings can inform decision-making, public health strategies, and policy development to protect vaccinated populations at elevated risk. The results support recommendations from Canada&apos;s National Advisory Committee on Immunisation for specific groups to remain current with COVID-19 vaccination to reduce severe outcomes.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Climate blind spots in malaria control: frontline perspectives on climate adaptation and malaria control in Zambia</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fitd-2026-1842769-295ce969/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fitd-2026-1842769-295ce969/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>Integrating environmental monitoring into routine disease management protocols could enhance operational resilience during overlapping health emergencies. Developing targeted training modules on ecological risk assessment may improve how local teams adjust interventions to shifting conditions.</description>
    <category>Malaria</category>
    <category>Cholera</category>
    <category>COVID-19</category>
    <category>Climate and environment</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Health policy</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>The Application and Impact of Digital Patient Decision Aids in COPD : A Scoping Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-jocn-70505-b5ee4456/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-jocn-70505-b5ee4456/</guid>
    <pubDate>Sun, 16 Aug 2026 00:00:00 GMT</pubDate>
    <description>The review frames digital patient decision aids as a possible support for shared decision-making in COPD, with outcome evidence centered on decision quality and user experience measures.</description>
    <category>AIDS</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Investigating the effectiveness of multimodal data in forecasting SARS-COV-2 case surges</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109062-7d805aff/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109062-7d805aff/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Incorporating supplementary information streams into routine monitoring networks may strengthen anticipatory capabilities for future viral circulation waves.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Maternal HIV viral load threshold for guiding extended infant prophylaxis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106779-e698d70a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106779-e698d70a/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings support a simplified risk-stratified approach to initiating extended infant postnatal prophylaxis, potentially enabling more targeted and resource-efficient prevention of mother-to-child HIV transmission during breastfeeding.</description>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Impact of EV-A71 vaccination and non-pharmaceutical interventions on hand, foot, and mouth disease: A 14-year interrupted time series analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106795-1705c1ac/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106795-1705c1ac/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The data illustrate how coordinated immunization efforts and temporary behavioral modifications can substantially suppress regional transmission cycles. Shifting pathogen dominance following targeted immunization suggests current prophylactic approaches may require broader formulation to address emerging viral variants.</description>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Cost-effectiveness of free influenza vaccination policy for Chinese older adults: a modeling analysis using real-world data</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128782-31151627/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128782-31151627/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The modeled results indicate that a fully funded influenza vaccination policy for older adults could reduce modeled influenza-related health outcomes while lowering societal costs in the evaluated setting. The abstract specifically highlights implementation for older adults, including the oldest age groups.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Vaccine uptake in the context of mandate announcement and removal: Evidence from Europe and North America</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128825-7a56d639/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128825-7a56d639/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Regulatory measures appear capable of producing temporary shifts in immunization behavior, underscoring the value of strategic communication and phased implementation to preserve coverage during administrative changes.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Vaccination policies for healthcare personnel in Europe, 2026</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128839-f5b67b79/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128839-f5b67b79/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings highlight persistent variation in healthcare worker vaccination policies across Europe despite recent expansion. The authors note that harmonized, evidence-based policies are needed to protect both healthcare personnel and patients amid resurgence of vaccine-preventable diseases.</description>
    <category>COVID-19</category>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Influenza</category>
    <category>Tetanus</category>
    <category>Zoster</category>
    <category>Hepatitis A</category>
    <category>Tuberculosis</category>
    <category>Mumps</category>
    <category>Rubella</category>
    <category>Varicella</category>
    <category>Hepatitis B</category>
    <category>Poliomyelitis</category>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Effectiveness of recombinant zoster vaccine against herpes zoster and postherpetic neuralgia: a systematic review and meta-analysis of post-licensure observational studies</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128842-36d8c80c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128842-36d8c80c/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesized data supply real-world effectiveness metrics that inform health policy regarding vaccine deployment across varied clinical risk categories and aging populations.</description>
    <category>Zoster</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Australian adults&apos; views on influenza vaccination: Implications for communication and service quality from a qualitative study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128846-d9886d88/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128846-d9886d88/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Immunization programs may achieve higher enrollment by aligning educational campaigns with accessible, patient-focused service models.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Elected officials’ online anti-vaccination statements respond to online engagement</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128901-32f06a9d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128901-32f06a9d/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings describe associations between social-media engagement, legislators&apos; anti-vaccination communication, and links to low-credibility sources. The abstract places these patterns in the context of political communication and public-health governance.</description>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Australians&apos; attitudes to mRNA vaccination in humans and animals: A cross-sectional survey</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128907-dee036dc/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128907-dee036dc/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors highlight the need for vaccine manufacturers and public- and animal-health policymakers to anticipate potentially lower public acceptance of mRNA vaccines and of animal-source foods derived from mRNA-vaccinated livestock, noting that scientific development must be matched by public acceptability for new vaccines to be optimally used.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Measles outbreaks as signals of governance failure: Lessons from Bangladesh&apos;s 2026 immunisation collapse</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128924-527b04f5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128924-527b04f5/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The work indicates that sustaining high immunization levels depends on stable administrative frameworks and clear accountability structures. It recommends evaluating health system management whenever unexpected disease increases occur without clear community resistance.</description>
    <category>Measles</category>
    <category>Rubella</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Expanding enhanced influenza vaccines programs for adults aged ≥65 in the Nordic region predicted to improve public health and health system resilience</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128934-45e5ca27/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128934-45e5ca27/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Scaling up advanced immunization protocols for senior citizens may reduce seasonal disease burden and alleviate pressure on medical facilities during peak viral circulation periods.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Cost-effectiveness analysis of a hypothetical vaccine for schistosomiasis in Madagascar and Burkina Faso</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128936-0b54e812/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128936-0b54e812/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The modeling results suggest that integrating adult demographics into future immunization campaigns could optimize resource allocation and disease reduction in highly affected regions. Policymakers might consider these economic parameters when planning next-generation preventive tools against this parasitic infection.</description>
    <category>Schistosomiasis</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>A systematic review of knowledge, attitudes, and behaviour towards Japanese encephalitis vaccination</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128999-3ae5f35e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128999-3ae5f35e/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Recognizing these informational deficits and structural hurdles enables stakeholders to design more effective outreach strategies aimed at expanding immunization rates within vulnerable demographics.</description>
    <category>Japanese Encephalitis</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Inflammatory biomarkers of asymptomatic and symptomatic tuberculosis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-75909-6-e2e28e53/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-75909-6-e2e28e53/</guid>
    <pubDate>Sat, 25 Jul 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest that biomarkers developed for symptomatic tuberculosis triage should not be directly adopted for community-based asymptomatic screening without additional optimization.</description>
    <category>Tuberculosis</category>
    <category>Diagnostics</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Regulatory Implications and Control Measures for Lumpy Skin Disease, Highly Pathogenic Avian Influenza, and Foot-and-Mouth Disease in European Livestock.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-v18070777-34f2cd01/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-v18070777-34f2cd01/</guid>
    <pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate>
    <description>The article addresses animal health and welfare, food security, and economic effects within the European livestock sector. It presents disease- and country-adapted vaccination policy and DIVA-based surveillance as approaches discussed in the article for supporting animal welfare and economic stability.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Slowing the spread of treatment failure to artemisinin-based combination therapies in Uganda</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-74737-y-6f2038f6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-74737-y-6f2038f6/</guid>
    <pubDate>Fri, 26 Jun 2026 00:00:00 GMT</pubDate>
    <description>The work addresses an urgent regional challenge by quantifying how strategic antimalarial policy adjustments could preserve drug efficacy and reduce clinical failures over a six-year timeframe.</description>
    <category>Malaria</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>&lt;i&gt;Streptococcus Pyogenes&lt;/i&gt; and Acute Rheumatic Fever: How Strong are the Links in the Chain?</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-5334-gh-1564-608dcc05/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-5334-gh-1564-608dcc05/</guid>
    <pubDate>Fri, 19 Jun 2026 00:00:00 GMT</pubDate>
    <description>The synthesized information supports ongoing discussions regarding prophylactic interventions and regulatory approvals for novel immunizations. Policy formulation benefits from understanding where current knowledge remains incomplete.</description>
    <category>Rheumatic fever</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Advancing diagnostics for Chagas disease: key product characteristics and harmonized evaluation strategies - an expert meeting report</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13565-3-2bd53b71/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13565-3-2bd53b71/</guid>
    <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
    <description>By establishing uniform evaluation criteria and mapping financial requirements, the report aims to accelerate the deployment of accessible testing instruments that align with regional elimination timelines.</description>
    <category>Chagas disease</category>
    <category>Diagnostics</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Effectiveness of seasonal mRNA COVID-19 vaccination against post COVID-19 condition between July 2023 and September 2024 among adults aged ≥ 60 years in Germany: a population-based cohort study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13803-8-cf9a44fe/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13803-8-cf9a44fe/</guid>
    <pubDate>Sat, 13 Jun 2026 00:00:00 GMT</pubDate>
    <description>The findings address vaccine-preventable PCC burden in a high-risk age group during the first post-pandemic season and are positioned as input for vaccination policy, communication, and clinical decision-making.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Health policy</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Inclusion of young adolescents in policy development for new tuberculosis vaccines.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s2214-109x-26-00017-3-75b4e89a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s2214-109x-26-00017-3-75b4e89a/</guid>
    <pubDate>Mon, 08 Jun 2026 00:00:00 GMT</pubDate>
    <description>Policymakers must integrate these operational hurdles into immunization planning to prevent systematic exclusion of younger demographics from emerging therapeutic protections.</description>
    <category>Tuberculosis</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Tick-borne encephalitis vaccination coverage among outdoor workers in Sweden: a nationwide survey</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128593-9785ac97/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128593-9785ac97/</guid>
    <pubDate>Fri, 01 May 2026 00:00:00 GMT</pubDate>
    <description>Rising regional disease incidence contrasts with the exclusion of the prophylactic agent from official immunization schedules, highlighting the need for occupational-specific interventions and financial support mechanisms to mitigate transmission risk.</description>
    <category>Tick-borne encephalitis</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Uptake and effectiveness of a novel seasonal influenza vaccination campaign for school-age children in the 2023/2024 influenza season in Shanghai, China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128478-c29116fc/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128478-c29116fc/</guid>
    <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
    <description>The findings indicate that a district-level vaccination campaign delivered through community healthcare centers may be relevant to efforts to increase influenza vaccination among school-age children. The abstract describes potential effects on other age groups, but it does not establish effects beyond the modeled setting.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Surveillance</category>
    <category>Health policy</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf680-1dec909d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf680-1dec909d/</guid>
    <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
    <description>The article provides an evidence-based framework for selecting antiviral treatments for adults with mild to moderate COVID-19. The supplied abstract does not report population-level outcomes or surveillance findings.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal RSV Infections in Immunocompromised Patients</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag117-456ee7d4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag117-456ee7d4/</guid>
    <pubDate>Mon, 02 Mar 2026 00:00:00 GMT</pubDate>
    <description>The article is relevant to vaccination policy and prevention planning for RSV among people with compromised immunity, a group identified in the abstract as experiencing more severe RSV outcomes. It also addresses coadministration with influenza and COVID-19 vaccines and vaccination status among eligible household members.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Overview of 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk Assessment Using Clinical Scoring Systems in Children and Adults</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag098-44827986/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag098-44827986/</guid>
    <pubDate>Sat, 14 Feb 2026 00:00:00 GMT</pubDate>
    <description>Universal testing for GAS pharyngitis incurs cost and inconvenience for low-risk individuals, while clinician judgment alone is unreliable. Standardized clinical scoring systems may improve diagnostic triage, helping to identify which patients warrant testing based on criteria including fever, tonsillar findings, cervical lymphadenopathy, and absence of cough.</description>
    <category>Group A streptococcal pharyngitis</category>
    <category>Health policy</category>
    <category>Diagnostics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Resurgence of rheumatic fever among Pacific peoples in Aotearoa New Zealand: A 2010–2023 analysis of hospitalisation data with implications for equity policy</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-anzjph-2025-100301-d7828ffc/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-anzjph-2025-100301-d7828ffc/</guid>
    <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
    <description>Addressing persistent disparities requires improved monitoring infrastructure and targeted resource allocation to achieve established national health objectives.</description>
    <category>Rheumatic fever</category>
    <category>COVID-19</category>
    <category>Surveillance</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1056-nejmsa2514268-02817cc7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1056-nejmsa2514268-02817cc7/</guid>
    <pubDate>Thu, 04 Dec 2025 00:00:00 GMT</pubDate>
    <description>The review addresses disrupted U.S. vaccine advisory processes by providing an independent evidence base to support immunization decisions against major respiratory viruses for the 2025–2026 season.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
</channel>
</rss>
